TGFB1 and neoplasm: Similarly, administration of TGF-β blocking antibody together with anti–PDL1, has successfully increased T-cell infiltration into the tumor bed, and ultimately led to tumor regression in EMT6 and MC38 immune excluded breast tumor models (130).